The University of British Columbia;British Columbia Cancer Agency Branch
发明人:
Yan, Luping,Andersen, Raymond J.,Sadar, Marianne Dorothy,Mawji, Nasrin R.,Banuelos, Carmen Adriana
申请号：
AU2019257509
公开号：
AU2019257509A1
申请日:
2019.10.31
申请国别(地区):
AU
年份:
2019
代理人:
摘要：
#$%^&*AU2019257509A120191121.pdf#####C: Interwoen NRPortbl DCC RBR 19490239_l.doex-31/10/2019 ABSTRACT Compounds having a structure of Structure I: R5 R6 R N R3 ,y2 R2 ' NR1 5 or a pharmaceutically acceptable salt, tautomer or stereoisomer thereof, wherein R, R2 , R3 , R4, R6, Y' and Y2 are as defined herein, and wherein at least one of R3 or R4 is a straightchain CI-C6 haloalkyl, are provided. Uses of such compounds for treatment of various indications, including prostate cancer, as well as methods of treatment involving such 10 compounds are also provided.
